HHS funds vaccine candidates for Marburg, Sudan ebolavirus

The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo. The last outbreaks of Marburg virus and Sudan ebolavirus were in Uganda, in 2017 and 2012, respectively. The Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of the vaccine candidates under a contract with HHS’s Biomedical Advanced Research and Development Authority. BARDA also is helping to develop and procure vaccines, therapeutics and diagnostics for the Ebola strain circulating in the Congo.
Related News Articles
Headline
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual…
Headline
A study published April 14 by JAMA Network Open found that rates of pancreatic and colon cancer rose among young adults from 2000-2021. Researchers examined…
Headline
The Centers for Medicare & Medicaid Services April 10 released key priorities for new CMS Administrator Mehmet Oz, who was confirmed to the position April…
Headline
People under age 50 who consume cannabis are 6.2 times more likely to experience a heart attack than individuals who do not, according to a study published by…
Headline
A study published March 26 by the National Institutes of Health and the University of Oxford found that individuals who engaged in light and moderate-to-…
Headline
Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie Feinour, vice president of operations at Novant Health…